SPENCER GALLNER: Open Payments
NPI 1780051995 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 9 payments from 5 companies in 2025. Trend: 2023 $75 · 2024 $136 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $78 |
| LivaNova USA, Inc. | 1 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| Janssen Pharmaceuticals, Inc | 1 | $35 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: VRAYLAR, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, CAPLYTA, SPRAVATO, Auvelity.
Industry payments across NE — which companies pay providers there.
